Cargando…
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
BACKGROUND: The outbreak and pandemic of coronavirus SARS-CoV-2 caused significant threaten to global public health and economic consequences. It is extremely urgent that global people must take actions to develop safe and effective preventions and therapeutics. Nanobodies, which are derived from si...
Autores principales: | Lu, Qizhong, Zhang, Zongliang, Li, Hexian, Zhong, Kunhong, Zhao, Qin, Wang, Zeng, Wu, Zhiguo, Yang, Donghui, Sun, Shuang, Yang, Nian, Zheng, Meijun, Chen, Qiang, Long, Cheng, Guo, Wenhao, Yang, Hui, Nie, Chunlai, Tong, Aiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844813/ https://www.ncbi.nlm.nih.gov/pubmed/33514385 http://dx.doi.org/10.1186/s12951-021-00768-w |
Ejemplares similares
-
Loss of furin site enhances SARS-CoV-2 spike protein pseudovirus infection
por: Wang, Zeng, et al.
Publicado: (2023) -
A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacy
por: Zhang, Zongliang, et al.
Publicado: (2023) -
Intercellular Adhesion Molecule-1 as Target for CAR-T-Cell Therapy of Triple-Negative Breast Cancer
por: Wei, Heng, et al.
Publicado: (2020) -
Genome-scale CRISPR–Cas9 screen reveals novel regulators of B7-H3 in tumor cells
por: Zhao, Shasha, et al.
Publicado: (2022) -
Evaluation of B7-H3 Targeted Immunotherapy in a 3D Organoid Model of Craniopharyngioma
por: Tang, Mei, et al.
Publicado: (2022)